https://histonedemethylase-sig....nal.com/index.php/me
Failure to react ended up being noticed in six clients (14.6%). Early T-cell precursor (ETP) (letter = 26) and non-ETP (letter = 15) clients had the same CR rate (80.8% vs 80.0%, P = .95). Among 41 customers, allo-HSCT ended up being successfully performed in 27 (66%) patients (22 in CR and 5 in non-CR). With a median follow-up time of 12 months, the predicted 2-year total success and event-free success had been 68.8% (95% CI
Curtir
Comentario
Compartilhar
